Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Schneider Electric Infrastructure (SCHNEIDER) shares fall 3.5% despite new factory expansion: What will November results reveal?
Read More Pharma Industry News Everest Medicines’ EVER001 shows promising Phase 1b/2a trial results for autoimmune kidney disease treatment Everest Medicines has announced promising preliminary results from its ongoing Phase 1b/2a clinical trial of EVER001, a next-generation… byPallavi MadhirajuDecember 4, 2024